Y CombinatorS21

Turning UK pharmacies into diagnostic centers, offering convenient testing services.

NJ-based Interpace Biosciences provides clinically beneficial molecular diagnostic tests and pathology services.

NexGen Arrays: Revolutionizing healthcare with our next-gen molecular diagnostic platform for robust, affordable pathogen detection.

SureGene, LLC: Advancing psychiatric care through genetic-based molecular diagnostic tools.

OrisDX: Pioneering non-invasive salivary tests for early oral cancer detection, based on University of Chicago research.

Mellitus: Innovating diabetes detection and monitoring through advanced in vitro diagnostic tests.

Veramarx provides the only 92% accurate early-stage Lyme disease diagnostic test, crucial for effective treatment.

ProteoGenix Inc. develops and commercializes diagnostic tests for pregnancy-related complications.

Stage I Diagnostics develops patented diagnostic tests for early cancer detection, focusing on prostate and ovarian types.

Applied Proteomics: Advancing proteomics with our protein biomarker discovery platform.

Phoresa: Innovating diagnostic tech for efficient, cost-effective patient care in infectious diseases.

IES Diagnostics: Rapid, accurate molecular diagnostic tests using proprietary technology, based in Pennsylvania.

Pierian Biosciences optimizes tech platforms for personalized cancer treatment strategies, enhancing patient life quality.

Talis develops innovative diagnostic platforms for rapid, complex testing in diverse healthcare settings.

ENTvantage Diagnostics develops in-office tests for ENT physicians to diagnose sinusitis causes, reducing unnecessary antibiotic use.

DioGenix, Inc. develops non-invasive diagnostic tests, specializing in early-stage MS detection and treatment response.

Nuclease Probe Technologies: Rapid infection testing and antibiotic guidance for improved patient care.

Anavasi Diagnostics: Rapid, affordable COVID-19 testing through advanced molecular technology.

First Light Diagnostics: Innovating rapid, accurate diagnostic tests for life-threatening pathogens.

Aviir, Inc. offers diagnostic tech for cardiovascular disease prevention and management, including wellness assessments.

Rapid Diagnostek: Biosensor-based diagnostic test developer for proteins, bacteria, and viruses.

Arterial Health International, LLC® offers comprehensive diagnostic tests for early detection of Cardiovascular Disease risk factors.

Ascendant Dx, an Arkansas-based medical organization, develops and validates proteomic diagnostic tests.

Y CombinatorW22

Spot: At-home lab test services for brands via a white-labeled platform.

TAI Diagnostics: A Wisconsin-based biotech firm offering non-invasive, sensitive tests for transplant patients.